Skip to main content

Breast Pain

  • Chapter
  • First Online:
Breast Diseases

Abstract

Breast pain or mastalgia is a frequent complaint among women and may interfere directly with the emotional, social, and professional life. It brings anguish and anxiety because women frequently related it to breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Recommended Reading

  1. Gong C, et al. A double-blind randomized controlled trial of toremifen therapy for Mastalgia. Arch Surg. 2006;141:43–7. Toremifen citrate has been shown to be effective in relieving the moderate and severe symptoms of cyclic mastalgia, in addition to improving non-cyclic breast pain. Its highest favorable point, relative to tamoxifen, is the lowest rate of side effects

    Article  CAS  Google Scholar 

  2. Goyal A, Mansel RE. A randomized multicenter study of gamolenic acid (Efamast) with and without antioxidant vitamins and minerals in the management of mastalgia. Breast J. 2005;11(1):41–7. 555 women with moderate to severe symptoms of cyclic mastalgia were randomized into four treatment groups: gamma-Linolenic acid and antioxidants, fatty acids and antioxidants, gamma-Linolenic acid and placebo, fatty acids and placebo. There was similar reduction of symptoms in the four groups. This study observed that the use of gamma-Linolenic acid did not differ in efficacy when compared to the use of placebos.

    Article  CAS  Google Scholar 

  3. Mansel R, Goyal A, Le Nestour E, Marsini-Etévé V, O’Connell K, Afimoxifene (4-OHT) Breast Pain Research Group. A phase II trial of Afimoxifene (4-hydroxytamoxifen gel) for cyclical mastalgia in premenopausal women. Breast Cancer Res Treat. 2007;106(3):389–97. Afimoxifene is a new antiestrogenic agent with a unique metabolic effect, and with a significant reduction of the mammary symptomatology. An attractive characteristic it presents is decrease of the side effects in relation to tamoxifen, since it does not undergo metabolism of the first hepatic passage.

    Article  CAS  Google Scholar 

  4. Srivastava A, Mansel RE, Arvind N, Prasad K, Dhar A, Chabra A. Evidence-based management of Mastalgia: a meta-analysis of randomised trials. Breast. 2007;16:503–12. Danazol, bromocriptine and tamoxifen are drugs that offer relative relief from the symptoms of mastalgia. No study compared the efficacy of the drugs to each other, but tamoxifen in small doses is the drug of choice. The use of gamma-Linolenic acid derivatives still lacks reliable studies.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Consortia

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

BBSG – Brazilian Breast Study Group. (2019). Breast Pain. In: Novita, G., Frasson, A., Millen, E., Zerwes, F., Cavalcante, F. (eds) Breast Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-13636-9_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-13636-9_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-13635-2

  • Online ISBN: 978-3-030-13636-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics